These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Heritable polymorphisms in oxidative drug metabolism]. Kallio J. Duodecim; 1990; 106(5):408-14. PubMed ID: 1670108 [No Abstract] [Full Text] [Related]
4. The relationship between imipramine metabolism and the sparteine oxidation polymorphism. Brøsen K. Dan Med Bull; 1988 Oct; 35(5):460-8. PubMed ID: 3066590 [No Abstract] [Full Text] [Related]
5. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications]. Eichelbaum M. Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670 [No Abstract] [Full Text] [Related]
13. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Butler MA, Guengerich FP, Kadlubar FF. Cancer Res; 1989 Jan 01; 49(1):25-31. PubMed ID: 2908851 [Abstract] [Full Text] [Related]
15. Standardization of mice by litter adjustment and the use of the 14-CO2 exhalation to assess drug metabolising capacity in rats. Netter KJ, Heubel F, Steffen C. Prog Clin Biol Res; 1986 Jan 01; 214():471-7. PubMed ID: 3088585 [No Abstract] [Full Text] [Related]